Subcontract Supply of Active Pharmaceutical Ingredients (API Sourcing)

The contract entails the supply of Bacitracin active pharmaceutical ingredient or finished ointment from alternate FDA-registered manufacturers to support the prime contractor’s fulfillment obligations under a Department of Defense agreement managed by the Defense Logistics Agency. This subcontract is specifically designed to ensure continuous and reliable access to Bacitracin, a critical component for military medical needs, by diversifying the supply chain through approved and compliant manufacturing sources. The scope focuses on securing materials that meet all regulatory and quality standards mandated by the FDA and applicable defense requirements, with performance tied to maintaining uninterrupted delivery to meet operational demands. The contract falls under the NAICS code 325412, which categorizes pharmaceutical and medicine manufacturing, and is structured as a subcontract under the broader defense procurement framework. Although specific location details for performance or point of contact are not provided, the agreement is centrally administered by the Defense Logistics Agency, indicating its importance to national defense medical logistics. The posting date of July 21, 2026, suggests this is a forward-looking procurement intended to secure supply capacity well in advance of anticipated demand timelines. The arrangement underscores strategic efforts to mitigate single-source risks and reinforce supply chain resilience for essential medications used in military healthcare systems.